Publications

Moriyama S, Brestoff JR, Flamar A-L, Moeller JB, Klose CSN, Rankin LC, Yudanin NA, Monticelli LA, Putzel GGarbès, Rodewald H-R, Artis D. β-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science. 2018;359(6379):1056-1061.

Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF. ZBTB46 defines and regulates ILC3s that protect the intestine. Nature. 2022;609(7925):159-165.

Han S-J, Zaretsky AGlatman, Andrade-Oliveira V, Collins N, Dzutsev A, Shaik J, da Fonseca DMorais, Harrison OJ, Tamoutounour S, Byrd AL, Smelkinson M, Bouladoux N, Bliska JB, Brenchley JM, Brodsky IE, Belkaid Y. White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection. Immunity. 2017;47(6):1154-1168.e6.

Iliev ID, Lin W-Y, Gaffen SL. When IL-17 gets on your nerves. Cell. 2023;186(3):466-468.

Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J, Soyer OS. What is the key challenge in engineering microbiomes?. Cell Syst. 2023;14(2):85-90.

Mourao-Sa D, Roy S, J Blander M. Vita-PAMPs: signatures of microbial viability. Adv Exp Med Biol. 2013;785:1-8.

Liu Z, Yang M, Peterfreund GL, Tsou AM, Selamoglu N, Daldal F, Zhong Z, Kan B, Zhu J. Vibrio cholerae anaerobic induction of virulence gene expression is controlled by thiol-based switches of virulence regulator AphB. Proc Natl Acad Sci U S A. 2011;108(2):810-5.

Hirten R, Longman RS, Bosworth BP, Steinlauf A, Scherl E. Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease. Am J Gastroenterol. 2015;110(12):1737-8.

Tsou AM, Liu Z, Cai T, Zhu J. The VarS/VarA two-component system modulates the activity of the Vibrio cholerae quorum-sensing transcriptional regulator HapR. Microbiology (Reading). 2011;157(Pt 6):1620-1628.

Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R. Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease. Inflamm Bowel Dis. 2022;28(12):1865-1871.

Malik F, Scherl E, Weber U, Carrino JA, Epsten M, Wichuk S, Pedersen SJ, Paschke J, Schwartzman S, Kroeber G, Maksymowych WP, Longman R, Mandl LA. Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study. Int J Rheum Dis. 2021;.

Nice TJ, Osborne LC, Tomov VT, Artis D, E Wherry J, Virgin HW. Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity. PLoS Pathog. 2016;12(6):e1005684.

Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J, Baldassano RN, Sonnenberg GF. Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat Med. 2016;22(3):319-23.

Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo C-J, Gerardin Y, Crawford CV, Jacob V, Scherl E, Brown S-E, Hambor J, Longman R. Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation. Gastroenterology. 2021;.

Sonnenberg GF. Transcriptionally defining ILC heterogeneity in humans. Nat Immunol. 2016;17(4):351-2.

Ravichandran V, Shameer Z, Kemel Y, Walsh M, Cadoo K, Lipkin S, Mandelker D, Zhang L, Stadler Z, Robson M, Offit K, Vijai J. Toward automation of germline variant curation in clinical cancer genetics. Genet Med. 2019;21(9):2116-2125.

J Blander M, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006;440(7085):808-12.

Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, Huang Y, Banerjee M, Overholtzer M, Roche PA, Tampé R, Brown BD, Amsen D, Whiteheart SW, J Blander M. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell. 2014;158(3):506-21.

Agudo J, Ruzo A, Kitur K, Sachidanandam R, J Blander M, Brown BD. A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade. Mol Ther. 2012;20(12):2257-67.

Chavez A, Tsou AM, F Johnson B. Telomeres do the (un)twist: helicase actions at chromosome termini. Biochim Biophys Acta. 2009;1792(4):329-40.

Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D. Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation. Mucosal Immunol. 2020;.

Mon KJoy Yee, J Blander M. TAP-ing into the cross-presentation secrets of dendritic cells. Curr Opin Immunol. 2023;83:102327.

Barbet G, Nair-Gupta P, Schotsaert M, Yeung ST, Moretti J, Seyffer F, Metreveli G, Gardner T, Choi A, Tortorella D, Tampé R, Khanna KM, Garcia-Sastre A, J Blander M. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming. Nat Immunol. 2021;22(4):497-509.

Collins N, Hochheiser K, Carbone FR, Gebhardt T. Sustained accumulation of antigen-presenting cells after infection promotes local T-cell immunity. Immunol Cell Biol. 2017;95(10):878-883.

Wang Y, Spitz MR, Tsou AMeng-Hsuan, Zhang K, Makan N, Wu X. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002;35(2):137-42.